Annual Current Assets
$19.07 M
-$8.38 M-30.54%
31 December 2023
Summary:
Aptevo Therapeutics annual total current assets is currently $19.07 million, with the most recent change of -$8.38 million (-30.54%) on 31 December 2023. During the last 3 years, it has fallen by -$33.50 million (-63.73%). APVO annual current assets is now -79.95% below its all-time high of $95.08 million, reached on 31 December 2017.APVO Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$10.01 M
+$433.00 K+4.52%
30 September 2024
Summary:
Aptevo Therapeutics quarterly total current assets is currently $10.01 million, with the most recent change of +$433.00 thousand (+4.52%) on 30 September 2024. Over the past year, it has dropped by -$9.05 million (-47.49%). APVO quarterly current assets is now -91.32% below its all-time high of $115.32 million, reached on 30 September 2017.APVO Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
APVO Current Assets Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | -47.5% |
3 y3 years | -63.7% | -81.0% |
5 y5 years | -36.4% | -66.6% |
APVO Current Assets High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -63.7% | at low | -81.0% | +4.5% |
5 y | 5 years | -63.7% | at low | -84.8% | +4.5% |
alltime | all time | -80.0% | at low | -91.3% | +4.5% |
Aptevo Therapeutics Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $10.01 M(+4.5%) |
June 2024 | - | $9.58 M(-20.7%) |
Mar 2024 | - | $12.07 M(-36.7%) |
Dec 2023 | $5.78 M(-14.6%) | $19.07 M(-9.8%) |
Sept 2023 | - | $21.13 M(-6.9%) |
June 2023 | - | $22.68 M(-20.4%) |
Mar 2023 | - | $28.48 M(+3.8%) |
Dec 2022 | $6.76 M(+67.8%) | $27.45 M(+11.5%) |
Sept 2022 | - | $24.62 M(-21.6%) |
June 2022 | - | $31.40 M(-24.6%) |
Mar 2022 | - | $41.67 M(-20.7%) |
Dec 2021 | $4.03 M(-35.8%) | $52.57 M(-10.7%) |
Sept 2021 | - | $58.87 M(-10.5%) |
June 2021 | - | $65.77 M(+4.6%) |
Mar 2021 | - | $62.85 M(+33.0%) |
Dec 2020 | $6.28 M | $47.26 M(+54.2%) |
Sept 2020 | - | $30.65 M(+192.3%) |
June 2020 | - | $10.49 M(-29.3%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2020 | - | $14.82 M(-50.6%) |
Dec 2019 | $23.41 M(+24.5%) | $30.00 M(-18.5%) |
Sept 2019 | - | $36.79 M(-15.8%) |
June 2019 | - | $43.67 M(-24.2%) |
Mar 2019 | - | $57.64 M(+18.4%) |
Dec 2018 | $18.80 M(-14.2%) | $48.69 M(-19.4%) |
Sept 2018 | - | $60.40 M(-8.8%) |
June 2018 | - | $66.25 M(-14.1%) |
Mar 2018 | - | $77.16 M(-18.9%) |
Dec 2017 | $21.92 M(+7.2%) | $95.08 M(-17.5%) |
Sept 2017 | - | $115.32 M(+71.6%) |
June 2017 | - | $67.19 M(-13.2%) |
Mar 2017 | - | $77.40 M(+8.4%) |
Dec 2016 | $20.44 M(-77.9%) | $71.41 M(-10.1%) |
Sept 2016 | - | $79.43 M(+99.3%) |
June 2016 | - | $39.85 M(-38.1%) |
Mar 2016 | - | $64.41 M(+83.3%) |
Dec 2015 | $92.63 M(+18.1%) | $35.13 M |
Dec 2014 | $78.42 M | - |
FAQ
- What is Aptevo Therapeutics annual total current assets?
- What is the all time high annual current assets for Aptevo Therapeutics?
- What is Aptevo Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Aptevo Therapeutics?
- What is Aptevo Therapeutics quarterly current assets year-on-year change?
What is Aptevo Therapeutics annual total current assets?
The current annual current assets of APVO is $19.07 M
What is the all time high annual current assets for Aptevo Therapeutics?
Aptevo Therapeutics all-time high annual total current assets is $95.08 M
What is Aptevo Therapeutics quarterly total current assets?
The current quarterly current assets of APVO is $10.01 M
What is the all time high quarterly current assets for Aptevo Therapeutics?
Aptevo Therapeutics all-time high quarterly total current assets is $115.32 M
What is Aptevo Therapeutics quarterly current assets year-on-year change?
Over the past year, APVO quarterly total current assets has changed by -$9.05 M (-47.49%)